Biography:

Aleida Lanza is a CoFounder of Zoelogix, parent company of Autism-U.  Along with her partners, including Debora L. Safko, BCBA, Aleida co-developed the world’s first and only artificially intelligent applied behavior analyst to democratize access to evidence-based behavioral health treatment and scale parity.  Aleida’s background as an electronic discovery and litigation support specialist helped to navigate the complexitiesin embedding interoperability.  She is an advocate dedicated to protecting the rights of  individuals with disabilities, previously served as Advocacy Chair for Autism Speaks South Florida Chapter, and continues her advocacy work to embed inclusion standards in healthcare, education, corrections, and business industries.

Abstract:

The need to scale access to parity is clear, now more than ever because it is no longer theory.  Parity has been reduced to code smart enough to enable self-directed treatment, and embeddable in every process across environments.  The answer to the need for parity is an artificially intelligent applied behavior analyst, to which you are now introduced.

We have spent a billion dollars in autism research and have learned that the primary treatment remains the same: unattainable to most in need.  Few are aware that a Federal court order precipitated CMS requiring states to cover Applied Behavior Analysis (“ABA”) for individuals with autism until they are 22.  This court order also ruled that withholding ABA from an individual with autism causes irreparable harm. 

The American Medical Association then revised its policy urging better access to behavior services in schools, while the U.S. Department of Education ignores the needs of its students with autism when more than half of U.S. states consistently fail IDEA requirements meant to protect our most vulnerable.  Instead, they abdicate intervention and criminalize the need for services they refuse to provide, violating the civil rights of most students with autism as standard operating procedure.

The American Academy of Pediatrics and the Centers for Disease Control has identified Applied Behavior Analysis (“ABA”) as the first-line treatment for autism spectrum disorder.  While the treatment rate remains at an average of 1:308 in the United States, nothing is done to bridge the gap in services. This deplorable statistic predicts a Trillion dollars in spending over the next ten years, and no plan to mitigate it.  Our nation’s current health and education policies work to disenfranchise 99% of the affected population from the primary treatment for their condition. 

Today, for the first time in history, anyone can go online and access ABA in the presence or absence of a clinician, and produce clinical treatment, analysis, and reporting that is consistent with current clinical standards. 

Democratized access to health will predict better outcomes, and you’re invited to join the Parity Project in your efforts to better serve your communities.  Let’s ensure every individual with autism has access to the first-line treatment: ABA.

Biography:

Aleida Lanza is a CoFounder of Zoelogix, parent company of Autism-U.  Along with her partners, including Debora L. Safko, BCBA, Aleida co-developed the world’s first and only artificially intelligent applied behavior analyst to democratize access to evidence-based behavioral health treatment and scale parity.  Aleida’s background as an electronic discovery and litigation support specialist helped to navigate the complexitiesin embedding interoperability.  She is an advocate dedicated to protecting the rights of  individuals with disabilities, previously served as Advocacy Chair for Autism Speaks South Florida Chapter, and continues her advocacy work to embed inclusion standards in healthcare, education, corrections, and business industries.

Abstract:

The need to scale access to parity is clear, now more than ever because it is no longer theory.  Parity has been reduced to code smart enough to enable self-directed treatment, and embeddable in every process across environments.  The answer to the need for parity is an artificially intelligent applied behavior analyst, to which you are now introduced.

We have spent a billion dollars in autism research and have learned that the primary treatment remains the same: unattainable to most in need.  Few are aware that a Federal court order precipitated CMS requiring states to cover Applied Behavior Analysis (“ABA”) for individuals with autism until they are 22.  This court order also ruled that withholding ABA from an individual with autism causes irreparable harm. 

The American Medical Association then revised its policy urging better access to behavior services in schools, while the U.S. Department of Education ignores the needs of its students with autism when more than half of U.S. states consistently fail IDEA requirements meant to protect our most vulnerable.  Instead, they abdicate intervention and criminalize the need for services they refuse to provide, violating the civil rights of most students with autism as standard operating procedure.

The American Academy of Pediatrics and the Centers for Disease Control has identified Applied Behavior Analysis (“ABA”) as the first-line treatment for autism spectrum disorder.  While the treatment rate remains at an average of 1:308 in the United States, nothing is done to bridge the gap in services. This deplorable statistic predicts a Trillion dollars in spending over the next ten years, and no plan to mitigate it.  Our nation’s current health and education policies work to disenfranchise 99% of the affected population from the primary treatment for their condition. 

Today, for the first time in history, anyone can go online and access ABA in the presence or absence of a clinician, and produce clinical treatment, analysis, and reporting that is consistent with current clinical standards. 

Democratized access to health will predict better outcomes, and you’re invited to join the Parity Project in your efforts to better serve your communities.  Let’s ensure every individual with autism has access to the first-line treatment: ABA.

Biography:

Christina Adams is an award-winning Media Professional, Researcher, former National Public Radio Commentator and Author of “A Real Boy: A True Story of Autism, Early Intervention and Recovery” (Penguin). After an aerospace PR career, Christina turned to autism after her son was diagnosed, becoming an expert in behavioral, dietary and medical interventions. Finding herself a single mom, she imported frozen Bedouin camel milk with USDA permission and her son got better on it overnight. She’s written a medical journal article and consults with doctors and scientists. She’s created a global network of health-seeking families, farmers and camel professionals. Regarding her media coverage, Christina and her work have appeared in Global Advances in Health & Medicine, The Washington Post, The Los Angeles Times, CHILD, NPR, GOOD, Web MD, The Kingsport Times-News, Orange County Register, Autism File, WebMD, National Public Television, Gulf News, Dubai One TV, Khaleej Times, KUCI, My Autistic Muslim Child & more.

Abstract:

With camel milk trending in the Huffington Post, Christina Adams MFA, an international speaker with a compelling personal story, is available; “The unofficial spokesperson for camel milk” Good magazine. Since author Christina Adams began investigating camel milk for her son in 2005, increasing evidence of its usefulness as an autism dietary intervention and scientific properties for diseases like diabetes, food allergies and more have emerged. Camel milk is a non-invasive, natural and accessible dietary intervention that appeals to families. Camel milk has become a global parent portal to autism treatment and awareness, as families in the early stages of autism read Adams’ publications online and connect to her seeking help. The author guides families to resources such as ABA, speech, OT, medical care and parental connections, as seen in UAE, India, Israel, Saudi Arabia and USA (plus Somali and Gypsy communities in the US). The author’s professional publications have inspired the camel milk industry in several countries, creating job growth; a positive and engaging blend of science, unique story and inspiration. The power of positive global change plus parental education and intuition will be emphasized